Peer Review History

Original SubmissionJune 3, 2021
Decision Letter - Marta Panzeri, Editor

PONE-D-21-18301Nurse’s Perceptions of Support for Sexual and Reproductive Issues in Adolescents and Young Adults with CancerPLOS ONE

Dear Dr. 富岡,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please update references

Please comment on the limitations of your study regarding aspects highlighted by reviewer #1

Please submit the paper to professional English proofreading and revised sentences according to reviewer #2

Please submit your revised manuscript by Jan 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Marta Panzeri, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the original language is written in non-Latin characters, for example Amharic, Chinese, or Korean, please use a file format that ensures these characters are visible.

3. Please state whether you validated the questionnaire prior to testing on study participants. Please provide details regarding the validation group within the methods section.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The subject of the article is interesting and quite innovative, it explores at the same time sexual, medical and reproductive issues together with cultural aspects.

Here are listed some aspects to ameliorate the manuscript:

- some references need to be updated; e.g., King L, Quinn GP, Vadaparampil ST, Gwede CK, Miree CA, Wilson C, et al. Oncology nurses’ perceptions of barriers to discussion of fertility preservation with patients with cancer. Clin J Oncol Nurs. 2008; 12(3): 467-476.

- line 68: “The survey period was from June to August 2016” – Authors can clarify/explicit the the reason why the decided to delay the publication.

- lines 197-198: “The low effective response rate in this study was a combination of missing answers and the considerable number of nurses who answered “I don’t know,” indicating that nurses themselves are not sufficiently aware of the current situation”. This statement sounds as an inference or a personal authors’ deduction and needs better explanation.

- line 70 “measurements”: nurses’ perception investigation could have been more specific, using one or more standardized questionnaire in association with the four questions.

- a comparison with other researches would have been appreciated, even if there are few studies on this topic. It could be interesting a comparison with nurses’ perception of support for sexual and reproductive issues in a different age, or for a different medical problem, or related to other form of support.

Reviewer #2: This study meets the criteria for publication as it presents the results of primary scientific research and the results have not been published elsewhere. The statistical analyses are appropriate and described in detail. All ethical standards are met. The study adheres to appropriate reporting guidelines and community standards for data availability.

This articles does have grammatical errors. In addition, statements at times are written in a very definitive manner, when not appropriate. The authors would benefit from having someone with a more nuanced understanding of the English language review and correct the paper. Please see 2 examples below.

“In addition, cancer treatments, such as chemotherapy and radiation, cause fertility and sexual dysfunction.” The more appropriate sentence would be “In addition, cancer treatments such as chemotherapy and radiation, may cause fertility and sexual dysfunction.” Not all chemotherapy and radiation treatments cause problems with fertility and sexual dysfunction.

Another example- “Receiving a diagnosis and the subsequent treatment of cancer during this life stage inevitably disrupts their outlook regarding a promising future.” This statement is very definitive and assumes the future is not promising. While getting diagnosed and treated for cancer will cause some disruption in the life of AYA’s, their future can still be promising and some patients even report psychological benefits from the cancer experience. Perhaps a preferable way to phrase the statement- “Receiving a diagnosis and the subsequent treatment of cancer during this life stage inevitably disrupts their life outlook.”

These are just 2 examples found throughout the article. This reviewer suggests having the authors review for grammatical errors and correct. In addition, this reviewer suggests reviewing whether definitive statements have research data to back up the conclusions stated.

The organization of the “free descriptions” was confusing as there are too many codes and categories. The authors may want to consider a more succinct way of organizing and reporting the qualitative information.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Valentina Cosmi

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Thank you for the opportunity to revise our manuscript. Please see our responses below.

Required

Editor

1. Comments to author

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response

We ensured that the style requirements were met and modified the filename.

2. Comments to author

Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the original language is written in non-Latin characters, for example Amharic, Chinese, or Korean, please use a file format that ensures these characters are visible.

Response

We have added Japanese and English questionnaires to Supporting Information.

3. Comments to author

Please state whether you validated the questionnaire prior to testing on study participants. Please provide details regarding the validation group within the methods section.

Response

We have stated that we have validated the questionnaire as follows:

“The researcher’s group consisting of four pediatric cancer nurses, two adult cancer nurses, and two clinical nurses reviewed the questionnaire for surface and content validity.”

4. Comments to author

In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability

Response

We have added the dataset to Supporting Information.

5. Comments to author

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response

We have revised the reference list and provided a rebuttal letter.

Reviewer

We wish to express our sincere appreciation to the reviewers for their insightful comments on our manuscript. As per the reviewers’ suggestions, we have revised the manuscript, and our responses to the reviewers’ comments are as follows:

Reviewer #1:

1. Comments to author

some references need to be updated; e.g., King L, Quinn GP, Vadaparampil ST, Gwede CK, Miree CA, Wilson C, et al. Oncology nurses’ perceptions of barriers to discussion of fertility preservation with patients with cancer. Clin J Oncol Nurs. 2008; 12(3): 467-476.

Response

Thank you for pointing this out. We have updated reference number14.

2. Comments to author

line 68: “The survey period was from June to August 2016” – Authors can clarify/explicit the reason why the decided to delay the publication.

Response

This study was part of a large survey on physicians, nurses, and patients across Japan in 2016, and after analyzing several surveys, we found it useful to focus and report on nurse’s perception of support for sexual and reproductive issues. Therefore, we decided to submit this manuscript. We have stated that this survey was part of a large study as follows:

“This study was part of a large survey across Japan. The questionnaire had six sections: a) care difficulties for AYA cancer patients/survivors, b) perceived needs of patients/survivors in daily care, c) support for sexual and reproductive issues, d) end-of-life care, e) characteristics of AYA patients/survivors whom nurses felt care difficulties, and f) facilitating/disturbing factors for the quality of care for AYAs. In this study, we used the questionnaire section ‘support for sexual and reproductive issues’.”

3. Comments to author

lines 197-198: “The low effective response rate in this study was a combination of missing answers and the considerable number of nurses who answered “I don’t know,” indicating that nurses themselves are not sufficiently aware of the current situation”. This statement sounds as an inference or a personal authors’ deduction and needs better explanation.

Response

Thank you for this suggestion. We agree with the reviewer and have removed the sentence because the low effective response does not indicate that the nurses are not sufficiently aware of the current situation.

4. Comments to author

line 70 “measurements”: nurses’ perception investigation could have been more specific, using one or more standardized questionnaire in association with the four questions.

Response

Thank you for this suggestion. This was the first exploratory study involving a multidisciplinary team in Japan, and we focused on the background and current status of the subjects. The survey questionnaire consisted of six sections and had many questions, so we did not use the standardized questionnaire for practical reasons. We would like challenge this with further research.

5. Comments to author

a comparison with other researches would have been appreciated, even if there are few studies on this topic. It could be interesting a comparison with nurses’ perception of support for sexual and reproductive issues in a different age, or for a different medical problem, or related to other form of support.

Response

Thank you for this suggestion. We have added the following text to the Discussion section to compare this study to previous studies investigating the perceptions of healthcare providers in the long-term care of adult cancer survivors:

“Similarly, in the services of adult cancer survivors, the smallest number of practitioners felt they had skills to manage sexual and reproductive issues. Nevertheless, training requirements were not highly prioritized[22].”

Reviewer #2:

1. Comments to author

This articles does have grammatical errors. In addition, statements at times are written in a very definitive manner, when not appropriate. The authors would benefit from having someone with a more nuanced understanding of the English language review and correct the paper. Please see 2 examples below.

“In addition, cancer treatments, such as chemotherapy and radiation, cause fertility and sexual dysfunction.” The more appropriate sentence would be “In addition, cancer treatments such as chemotherapy and radiation, may cause fertility and sexual dysfunction.” Not all chemotherapy and radiation treatments cause problems with fertility and sexual dysfunction.

Another example- “Receiving a diagnosis and the subsequent treatment of cancer during this life stage inevitably disrupts their outlook regarding a promising future.” This statement is very definitive and assumes the future is not promising. While getting diagnosed and treated for cancer will cause some disruption in the life of AYA’s, their future can still be promising and some patients even report psychological benefits from the cancer experience. Perhaps a preferable way to phrase the statement- “Receiving a diagnosis and the subsequent treatment of cancer during this life stage inevitably disrupts their life outlook.”

These are just 2 examples found throughout the article. This reviewer suggests having the authors review for grammatical errors and correct. In addition, this reviewer suggests reviewing whether definitive statements have research data to back up the conclusions stated.

Response

Thank you for this suggestion. We have revised two sentences based on your suggestion. Moreover, we have proofread the manuscript again.

 

2. Comments to author

The organization of the “free descriptions” was confusing as there are too many codes and categories. The authors may want to consider a more succinct way of organizing and reporting the qualitative information.

Response

Thank you for this suggestion. We have simplified the code because there are several qualitative codes. Moreover, we have shown only one.

All abovementioned changes have been reflected in the manuscript in red text.

We hope you find the revised manuscript acceptable for publication. Thank you once again for the consideration.

Attachments
Attachment
Submitted filename: Respons to Reviewers.docx
Decision Letter - Marta Panzeri, Editor

Nurse’s Perceptions of Support for Sexual and Reproductive Issues in Adolescents and Young Adults with Cancer

PONE-D-21-18301R1

Dear Dr. 富岡,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Marta Panzeri, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The suggested changes were made. The only additional change relates to the first sentence in the conclusions section. Please change the word "several" to "some."

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Valentina Cosmi

Reviewer #2: No

Formally Accepted
Acceptance Letter - Marta Panzeri, Editor

PONE-D-21-18301R1

Nurse’s perceptions of support for sexual and reproductive issues in adolescents and young adults with cancer

Dear Dr. Tomioka:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Marta Panzeri

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .